HomeCompareCLOZ vs JNJ

CLOZ vs JNJ: Dividend Comparison 2026

CLOZ yields 7.97% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CLOZ wins by $13.9K in total portfolio value
10 years
CLOZ
CLOZ
● Live price
7.97%
Share price
$25.65
Annual div
$2.04
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$33.9K
Annual income
$1,319.65
Full CLOZ calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — CLOZ vs JNJ

📍 CLOZ pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCLOZJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CLOZ + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CLOZ pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CLOZ
Annual income on $10K today (after 15% tax)
$677.38/yr
After 10yr DRIP, annual income (after tax)
$1,121.70/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, CLOZ beats the other by $418.09/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CLOZ + JNJ for your $10,000?

CLOZ: 50%JNJ: 50%
100% JNJ50/50100% CLOZ
Portfolio after 10yr
$27.0K
Annual income
$1,073.71/yr
Blended yield
3.98%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

CLOZ
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CLOZ buys
0
JNJ buys
0
No recent congressional trades found for CLOZ or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCLOZJNJ
Forward yield7.97%3.36%
Annual dividend / share$2.04$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$33.9K$20.0K
Annual income after 10y$1,319.65$827.78
Total dividends collected$10.6K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: CLOZ vs JNJ ($10,000, DRIP)

YearCLOZ PortfolioCLOZ Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,497$796.91$10,676$355.77+$821.00CLOZ
2$13,158$856.26$11,407$389.39+$1.8KCLOZ
3$14,995$915.87$12,198$426.53+$2.8KCLOZ
4$17,020$975.44$13,056$467.62+$4.0KCLOZ
5$19,246$1,034.75$13,987$513.12+$5.3KCLOZ
6$21,687$1,093.54$14,998$563.56+$6.7KCLOZ
7$24,357$1,151.61$16,098$619.52+$8.3KCLOZ
8$27,270$1,208.76$17,295$681.69+$10.0KCLOZ
9$30,444$1,264.82$18,599$750.82+$11.8KCLOZ
10$33,895$1,319.65$20,022$827.78+$13.9KCLOZ

CLOZ vs JNJ: Complete Analysis 2026

CLOZStock

The fund is an actively-managed exchange-traded fund (“ETF”) that pursues its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings made for investment purposes) in collateralized loan obligations (“CLOs”) that are rated, at the time of purchase, between BBB+ and B- or an equivalent rating by a NRSRO. It is non-diversified.

Full CLOZ Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this CLOZ vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CLOZ vs SCHDCLOZ vs JEPICLOZ vs OCLOZ vs KOCLOZ vs MAINCLOZ vs ABBVCLOZ vs MRKCLOZ vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.